| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.033 | 0.8 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.006 | 0.8 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.034 | 0.8 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.8 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.8 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.8 |